Here is the presentation presented on March 1st 2011 at the SFU Time Centre.
Promotion Banner
Tuesday, March 1, 2011
2011 Life Science Emerging Rockets List
Agrisoma Biosciences Inc.
ARC Medical Devices Inc.
Augurex Life Sciences Corp.
Bionic Power Inc.
Cellfor Inc
Cogent Health Solutions Inc.
Del Mar Pharmaceuticals.
enGene Inc.
Indel Therapeutics Inc.
Inimex Pharmaceuticals Inc.
Superna Life Sciences
Valocor Therapeutics, Inc
VanRx PharmaSystems Inc.
viDA Therapeutics
Zymeworks Inc.
ARC Medical Devices Inc.
Augurex Life Sciences Corp.
Bionic Power Inc.
Cellfor Inc
Cogent Health Solutions Inc.
Del Mar Pharmaceuticals.
enGene Inc.
Indel Therapeutics Inc.
Inimex Pharmaceuticals Inc.
Superna Life Sciences
Valocor Therapeutics, Inc
VanRx PharmaSystems Inc.
viDA Therapeutics
Zymeworks Inc.
2011 "Ready to Rocket" Life Science List
Announcing 2011 Ready to Rocket Life Science List
Rocket Builders Names Top Companies to “Ready to Rocket” Life Science List
BC’s Life Science companies positioned for significant milestones in 2011
VANCOUVER, BC – March 1, 2011
Rocket Builders today released its first-ever “Ready to Rocket” list of B.C. Life Science technology companies. The ten privately-held companies are positioned to achieve significant milestones in 2011 that will lead them to rapid growth and investment.
The “Ready to Rocket” recognition list is the only predictive list of its kind in North America.
Life Science technology encompasses Biotechnology, Pharmaceuticals, Diagnostics, Medical Devices, Healthcare Information Technology and other innovations improving health. British Columbia has a diversified mix of companies across all of these areas.
According to Thealzel Lee, Senior Partner at Rocket Builders, “B.C. has a strong tradition of creating successful companies in Life Science sectors like biotechnology and medical devices. With strong academic and preclinical research centres, many experienced entrepreneurs, and an active community of angel investors, B.C. has a great climate to generate Life Science companies with great potential.”
The life science industry came through the recent recession remarkably well, with global growth between 4% and 6% and it is forecast to grow globally at 5% to 7% over the next 3 years. In emerging markets like South America, Asia and Russia, growth is over 15%.
The climate for investment is very positive for Life Science companies. "Last year, Life Science investment in Canada jumped 38 per cent over 2009,” said Geoffrey Hansen, Managing Partner at Rocket Builders. “And with growing demand for biotechnology and medical devices in emerging markets like China and India, the investment prospects for young innovative companies from Canada are very good."
Concurrent with the 2011 ”Ready to Rocket Life Science” list, Rocket Builders also released a list of “Emerging Rockets” of fifteen additional B.C. Life Science companies that hold potential for breakthroughs in the coming years.
BC’s Life Science companies positioned for significant milestones in 2011
VANCOUVER, BC – March 1, 2011
Rocket Builders today released its first-ever “Ready to Rocket” list of B.C. Life Science technology companies. The ten privately-held companies are positioned to achieve significant milestones in 2011 that will lead them to rapid growth and investment.
The “Ready to Rocket” recognition list is the only predictive list of its kind in North America.
Life Science technology encompasses Biotechnology, Pharmaceuticals, Diagnostics, Medical Devices, Healthcare Information Technology and other innovations improving health. British Columbia has a diversified mix of companies across all of these areas.
According to Thealzel Lee, Senior Partner at Rocket Builders, “B.C. has a strong tradition of creating successful companies in Life Science sectors like biotechnology and medical devices. With strong academic and preclinical research centres, many experienced entrepreneurs, and an active community of angel investors, B.C. has a great climate to generate Life Science companies with great potential.”
The life science industry came through the recent recession remarkably well, with global growth between 4% and 6% and it is forecast to grow globally at 5% to 7% over the next 3 years. In emerging markets like South America, Asia and Russia, growth is over 15%.
The climate for investment is very positive for Life Science companies. "Last year, Life Science investment in Canada jumped 38 per cent over 2009,” said Geoffrey Hansen, Managing Partner at Rocket Builders. “And with growing demand for biotechnology and medical devices in emerging markets like China and India, the investment prospects for young innovative companies from Canada are very good."
Concurrent with the 2011 ”Ready to Rocket Life Science” list, Rocket Builders also released a list of “Emerging Rockets” of fifteen additional B.C. Life Science companies that hold potential for breakthroughs in the coming years.
Subscribe to:
Posts (Atom)